These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11338474)

  • 1. Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
    Banner BF; Savas L; Zivny J; Tortorelli K; Bonkovsky HL
    Am J Clin Pathol; 2000 Dec; 114(6):860-6. PubMed ID: 11338474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis.
    Yamauchi N; Itoh Y; Tanaka Y; Mizokami M; Minami M; Morita A; Toyama T; Yamaguchi K; Fujii H; Okanoue T
    J Gastroenterol; 2004 Jul; 39(7):654-60. PubMed ID: 15293136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations.
    Neri S; Pulvirenti D; Signorelli S; Ignaccolo L; Tsami A; Mauceri B; Misseri M; Interlandi D; Cutuli N; Castellino P
    Intern Med J; 2008 Apr; 38(4):254-8. PubMed ID: 17916170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic hemochromatosis and the HFE gene: from molecular genetics to clinical diagnosis].
    Höhler T; Gerken G
    Z Gastroenterol; 2000 Jun; 38(6):509-15. PubMed ID: 10923364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
    Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis.
    Simsek H; Balaban YH; Sümer H; Yilmaz E; Tatar G
    Dig Dis Sci; 2006 Oct; 51(10):1723-4. PubMed ID: 16964543
    [No Abstract]   [Full Text] [Related]  

  • 14. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterozygosis H63D in patients with steatohepatitis and chronic hepatitis C].
    Pulvirenti D; Neri S; Bertino G; Cutuli N; Ignaccolo L; Misseri M; Tsami A; Caruso L
    Clin Ter; 2006; 157(6):485-8. PubMed ID: 17228846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
    Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
    Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.
    Pirisi M; Scott CA; Avellini C; Toniutto P; Fabris C; Soardo G; Beltrami CA; Bartoli E
    Am J Clin Pathol; 2000 Apr; 113(4):546-54. PubMed ID: 10761457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome].
    Laroussi N; Mosnier JF; Morel Y; Deugnier Y; Dumas O; Audigier JC
    Gastroenterol Clin Biol; 2002 May; 26(5):475-9. PubMed ID: 12122357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.